Odyssey Therapeutics, Inc. (ODTX)

Healthcare · Biotechnology · NASDAQ

Odyssey Therapeutics, Inc. (ODTX) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $1.12B and a free-cash-flow yield of -20.3%. Over the most recent reported fiscal year, revenue declined 33.5%.

Market cap	$1.12B
Trailing P/E	—
FCF yield	-20.3%
Revenue growth (YoY)	-33.5%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live ODTX data on Nama Insights →